Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul-Aug;46(4):210-216.
doi: 10.1097/NAN.0000000000000508.

Effect of Peripherally Infused Norepinephrine on Reducing Central Venous Catheter Utilization

Affiliations

Effect of Peripherally Infused Norepinephrine on Reducing Central Venous Catheter Utilization

Sara M Powell et al. J Infus Nurs. 2023 Jul-Aug.

Abstract

The purpose of this retrospective study was to evaluate the impact of peripherally administered norepinephrine on avoiding central venous catheter insertion while maintaining safety of the infusion. An institutional guideline allows peripheral infusion of norepinephrine via dedicated, 16- to 20-gauge, mid-to-upper arm intravenous (IV) catheters for up to 24 hours. The primary outcome was the need for central venous access in patients initially started on peripherally infused norepinephrine. A total of 124 patients were evaluated (98 initially on peripherally infused norepinephrine vs 26 with central catheter only administration). Thirty-six (37%) of the 98 patients who were started on peripheral norepinephrine avoided the need for central catheter placement, which was associated with $8,900 in direct supply cost avoidance. Eighty (82%) of the 98 patients who started peripherally infused norepinephrine required the vasopressor for ≤12 hours. No extravasation or local complications were observed in any of the 124 patients, regardless of site of infusion. Administration of norepinephrine via a dedicated peripheral IV site appears safe and may lead to a reduction in the need for subsequent central venous access. To achieve timely resuscitation goals, as well as to minimize complications associated with central access, initial peripheral administration should be considered for all patients.

PubMed Disclaimer

Conflict of interest statement

Disclosures: No relevant conflicts of interest to disclose.

References

    1. Ong J, Van Gerpen R. Recommendations for the management of noncytotoxic vesicant extravasations. J Infus Nurs. 2020;43(6):319–343. doi:10.1097/NAN.0000000000000392
    1. Plum M, Moukhachen O. Alternative pharmacological management of vasopressor extravasation in the absence of phentolamine. P T. 2017;42(9):581–592.
    1. Gorski LA, Hadaway L, Hagle ME, et al. Infusion therapy standards of practice. J Infus Nurs. 2021;44(suppl 1):S1–S224. doi:10.1097/NAN.0000000000000396
    1. Patel AR, Patel AR, Singh S, Singh S, Khawaja I. Central line catheters and associated complications: a review. Cureus. 2019;11(5):e4717. doi:10.7759/cureus.4717
    1. Kornbau C, Lee KC, Hughes GD, Firstenberg MS. Central line complications. Int J Crit Illn Inj Sci. 2015;5(3):170–178. doi:10.4103/2229-5151.164940

MeSH terms

LinkOut - more resources